Who founded ReviveMed?

ReviveMed was founded by Leila Pirhaji in 2016.

Who are ReviveMed's investors?

ReviveMed's investors include Good Growth Capital, MassChallenge, Team Builder Ventures, TechU Ventures, WorldQuant Ventures.

How much funding has ReviveMed raised?

ReviveMed has disclosed $1.5M raised across 1 round.

Where is ReviveMed headquartered?

ReviveMed is headquartered in Cambridge, US.

ReviveMed

Cambridge, US · Founded 2016 · Delaware corporation · 5 known investors

Find your way into ReviveMed

494 people in our graph share verified history with the ReviveMed team — schools, employers, funds. One of them is your warm intro.

Noubar Afeyanunlockedknows Leila Pirhaji · together at Massachusetts Institute of Technology (MIT) (overlapped)

×7knows the team · via Massachusetts Institute of Technology (MIT)

×2knows the team · via University of Tehran

×2knows the team · via Takeda Oncology

RreviveMed applies artificial intelligence to metabolomics and biology to support drug discovery in the pharmaceutical and biotech sector.

AI & Machine Learning Biotech Healthtech

Founders & leadership

ReviveMed was founded in 2016 by Leila Pirhaji.

Leila Pirhaji inFounderLeila Pirhaji holds a PhD in Biological Engineering from MIT and trained at ETH Zürich; she founded ReviveMed to apply AI and generative models to metabolomics for drug discovery, with adoption across major pharmaceutical companies, and previously held roles in industry at Merck and Takeda.

Andrey Zarur inNamed on SEC filingExecutive Officer, Director at GreenLight Biosciences

Carlos GonzalezNamed on SEC filing

Ernest FraenkelinNamed on SEC filing

Investors · 5

Good Growth CapitalCharleston

MassChallengereported

Team Builder VenturesreportedSan Francisco

TechU VenturesreportedCedarhurst

WorldQuant VenturesreportedOld Greenwich

Reported raises · per SEC filings

Form D private placements

$1.5M disclosed across 1 round · 2018

▶$1.5MraisedApr 2018 · 11 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Andrey ZarurDirector
Carlos GonzalezDirector
Leila PirhajiExecutive Officer, Director
Ernest FraenkelDirector

Offering amount: $1.5M
Amount sold: $1.5M
First sale: Jan 2018
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

ReviveMed Raises $1.5M in Seed Funding - FinSMEsfinsmes.com · Apr 2018

MIT Spinout, ReviveMed, Raises $1.5M to Advance its AI-Driven Metabolomic Platform for Drug Discovery - BioSpacebiospace.com · Apr 2018

ReviveMed turns drug discovery into a big data problem and raises $1.5M to solve it - The Martin Trust Center for MIT Entrepreneurshipentrepreneurship.mit.edu · Apr 2018

MIT Drug-Discovery Spinout ReviveMed Raises $1.5M | GenomeWebgenomeweb.com · Apr 2018

ReviveMed - Wiki | Goldengolden.com

Frequently asked questions

What does ReviveMed do?: RreviveMed applies artificial intelligence to metabolomics and biology to support drug discovery in the pharmaceutical and biotech sector.
Who founded ReviveMed?: ReviveMed was founded by Leila Pirhaji in 2016.
Who are ReviveMed's investors?: ReviveMed's investors include Good Growth Capital, MassChallenge, Team Builder Ventures, TechU Ventures, WorldQuant Ventures.
How much funding has ReviveMed raised?: ReviveMed has disclosed $1.5M raised across 1 round.
Where is ReviveMed headquartered?: ReviveMed is headquartered in Cambridge, US.